Amylyx Pharmaceuticals (AMLX) Stock Forecast & Price Target

AMLX$30.29+0.43 +1.44%
BiotechnologyGrowth Stock
Compare
Market cap$3.89BEnterprise value$3.65BRevenue (TTM)$0Market position—

Score

66
Bullish
Value
49
Quality
48
Growth
100

Amylyx Pharmaceuticals, Inc. price target

AMLX
Low$42.00
Average$52.20
High$57.00
Upside vs current price+72.3%

The average target of $52.20 is +72.3% versus the current AMLX price of $30.29.

Amylyx Pharmaceuticals, Inc. analyst ratings

RatingAnalysts
Strong buy0
Buy11
Hold1
Sell0
Strong sell0
ConsensusBuy

12 analysts cover AMLX.

Amylyx Pharmaceuticals, Inc. EPS and revenue estimates

AMLX shows the next fiscal years with at least three analysts: 2026 EPS $-1.50, 2027 EPS $-1.13. A thinner year is left off this table.

Fiscal yearEPS estimateRevenue estimate
2026$-1.50$80,625
2027$-1.13$56.55M

Is Amylyx Pharmaceuticals, Inc. a buy or sell?

Of the 12 analysts covering Amylyx Pharmaceuticals, Inc., 11 rate it a buy (0 strong buy and 11 buy), 1 rates it a hold, and 0 rate it a sell (0 sell and 0 strong sell).

The AMLX consensus label is Buy, beside 11 buy-side ratings and 0 sell-side ratings.

The average target of $52.20 implies +72.3% versus the current price of $30.29.

Those 12 ratings on AMLX are a headcount, and the label on file is Buy.

Reading the Amylyx Pharmaceuticals, Inc. forecast

The AMLX target band runs from $42.00 to $57.00. The average inside that band is $52.20.

Set next to the $30.29 AMLX quote, that average is +72.3%.

Ratings on the Amylyx Pharmaceuticals, Inc. cluster: 11 of 12 analysts are on the buy side, 1 is at hold, and 0 are on the sell side, and the published consensus is Buy.

The AMLX EPS path from 2026 ($-1.50) to 2027 ($-1.13) is rising.

Only 12 analysts cover AMLX, so the average rests on a short list.

Amylyx Pharmaceuticals, Inc. forecast questions

What is the AMLX price target?

The published range for AMLX is $42.00 to $57.00, with an average of $52.20. That average is +72.3% versus the current price of $30.29.

Is Amylyx Pharmaceuticals, Inc. a buy or sell?

Of the 12 analysts covering Amylyx Pharmaceuticals, Inc., 11 rate it a buy, 1 rates it a hold, and 0 rate it a sell. The consensus is Buy, and the AMLX headcount is 11 buy, 1 hold, and 0 sell.

What is the EPS estimate for Amylyx Pharmaceuticals, Inc.?

Analyst EPS estimates for Amylyx Pharmaceuticals, Inc.: 2026 $-1.50, 2027 $-1.13.

What is the revenue estimate for Amylyx Pharmaceuticals, Inc.?

Analyst revenue estimates for Amylyx Pharmaceuticals, Inc.: 2026 $80,625, 2027 $56.55M.

How many analysts cover AMLX?

12 analysts cover AMLX. Their consensus on AMLX is Buy, across those 12.

AMLX price $30.29 +0.43 +1.44%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener